BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 30178263)

  • 1. Modulation of Host Cell Processes by T3SS Effectors.
    Shenoy AR; Furniss RCD; Goddard PJ; Clements A
    Curr Top Microbiol Immunol; 2018; 416():73-115. PubMed ID: 30178263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamics of expression, secretion and translocation of type III effectors during enteropathogenic Escherichia coli infection.
    Serapio-Palacios A; Finlay BB
    Curr Opin Microbiol; 2020 Apr; 54():67-76. PubMed ID: 32058947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Type III Secretion System of Pathogenic Escherichia coli.
    Slater SL; Sågfors AM; Pollard DJ; Ruano-Gallego D; Frankel G
    Curr Top Microbiol Immunol; 2018; 416():51-72. PubMed ID: 30088147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EspFu-Mediated Actin Assembly Enhances Enteropathogenic
    Martins FH; Kumar A; Abe CM; Carvalho E; Nishiyama-Jr M; Xing C; Sperandio V; Elias WP
    mBio; 2020 Apr; 11(2):. PubMed ID: 32291304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tight Junction Disruption Induced by Type 3 Secretion System Effectors Injected by Enteropathogenic and Enterohemorrhagic Escherichia coli.
    Ugalde-Silva P; Gonzalez-Lugo O; Navarro-Garcia F
    Front Cell Infect Microbiol; 2016; 6():87. PubMed ID: 27606286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salmonella, E. coli, and Citrobacter Type III Secretion System Effector Proteins that Alter Host Innate Immunity.
    El Qaidi S; Wu M; Zhu C; Hardwidge PR
    Adv Exp Med Biol; 2019; 1111():205-218. PubMed ID: 30411307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bringing down the host: enteropathogenic and enterohaemorrhagic Escherichia coli effector-mediated subversion of host innate immune pathways.
    Santos AS; Finlay BB
    Cell Microbiol; 2015 Mar; 17(3):318-32. PubMed ID: 25588886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Serine Protease EspC from Enteropathogenic Escherichia coli Regulates Pore Formation and Cytotoxicity Mediated by the Type III Secretion System.
    Guignot J; Segura A; Tran Van Nhieu G
    PLoS Pathog; 2015 Jul; 11(7):e1005013. PubMed ID: 26132339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extra! Extracellular Effector Delivery into Host Cells via the Type 3 Secretion System.
    Kendall MM
    mBio; 2017 May; 8(3):. PubMed ID: 28465427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of the Inflammasome Signaling Pathway by Enteropathogenic and Enterohemorrhagic Escherichia coli.
    Yen H; Karino M; Tobe T
    Front Cell Infect Microbiol; 2016; 6():89. PubMed ID: 27617233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Host cell attachment elicits posttranscriptional regulation in infecting enteropathogenic bacteria.
    Katsowich N; Elbaz N; Pal RR; Mills E; Kobi S; Kahan T; Rosenshine I
    Science; 2017 Feb; 355(6326):735-739. PubMed ID: 28209897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enteropathogenic and enterohaemorrhagic Escherichia coli: even more subversive elements.
    Wong AR; Pearson JS; Bright MD; Munera D; Robinson KS; Lee SF; Frankel G; Hartland EL
    Mol Microbiol; 2011 Jun; 80(6):1420-38. PubMed ID: 21488979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host Cell Targeting by Enteropathogenic Bacteria T3SS Effectors.
    Pinaud L; Sansonetti PJ; Phalipon A
    Trends Microbiol; 2018 Apr; 26(4):266-283. PubMed ID: 29477730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effector triggered manipulation of host immune response elicited by different pathotypes of Escherichia coli.
    Jayamani E; Mylonakis E
    Virulence; 2014; 5(7):733-9. PubMed ID: 25513774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Host Proteins and Signaling Pathways in Enteropathogenic E. coli Pathogenesis Identified by Global Phosphoproteome Analysis.
    Scholz R; Imami K; Scott NE; Trimble WS; Foster LJ; Finlay BB
    Mol Cell Proteomics; 2015 Jul; 14(7):1927-45. PubMed ID: 25944883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A type III effector antagonizes death receptor signalling during bacterial gut infection.
    Pearson JS; Giogha C; Ong SY; Kennedy CL; Kelly M; Robinson KS; Lung TW; Mansell A; Riedmaier P; Oates CV; Zaid A; Mühlen S; Crepin VF; Marches O; Ang CS; Williamson NA; O'Reilly LA; Bankovacki A; Nachbur U; Infusini G; Webb AI; Silke J; Strasser A; Frankel G; Hartland EL
    Nature; 2013 Sep; 501(7466):247-51. PubMed ID: 24025841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-Dependent Susceptibility to Enteropathogenic Escherichia coli (EPEC) Infection in Mice.
    Dupont A; Sommer F; Zhang K; Repnik U; Basic M; Bleich A; Kühnel M; Bäckhed F; Litvak Y; Fulde M; Rosenshine I; Hornef MW
    PLoS Pathog; 2016 May; 12(5):e1005616. PubMed ID: 27159323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pathogenic E. coli type III effector EspZ interacts with host CD98 and facilitates host cell prosurvival signalling.
    Shames SR; Deng W; Guttman JA; de Hoog CL; Li Y; Hardwidge PR; Sham HP; Vallance BA; Foster LJ; Finlay BB
    Cell Microbiol; 2010 Sep; 12(9):1322-39. PubMed ID: 20374249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recruitment and membrane interactions of host cell proteins during attachment of enteropathogenic and enterohaemorrhagic Escherichia coli.
    Munera D; Martinez E; Varyukhina S; Mahajan A; Ayala-Sanmartin J; Frankel G
    Biochem J; 2012 Aug; 445(3):383-92. PubMed ID: 22587461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enteropathogenic E. coli relies on collaboration between the formin mDia1 and the Arp2/3 complex for actin pedestal biogenesis and maintenance.
    Velle KB; Campellone KG
    PLoS Pathog; 2018 Dec; 14(12):e1007485. PubMed ID: 30550556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.